Allogeneic transplant for older AML patients - who, when and how
The prognostic value of IDH1 and IDH2 in acute myeloid leukemia (AML)
Rigosertib in combination with azacitidine: a potential treatment for AML?
HARMONY: a collaboration between 51 partners
History of gene therapies